from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1835c/-

LFCtreatmentdescriptionclass of inhibitor

-0.340

Amikacinug/mL Amikacintranslation

0.309

Cap5-10ug/mL Capreomycintranslation

-0.332

Rox10-50 ug/mL Roxithromycintranslation

-0.451

SM2-5 ug/mL Streptomycintranslation

1.016

Tet5-10 ug/mL Tetracyclinetranslation

0.693

Rif0.2-5ug/mL Rifampicintranscription

-0.321

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.374

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.431

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.065

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.011

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.334

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.724

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.876

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-2.111

NaN30.2-2 mM Sodium aziderespiration

-0.495

Nigericin50 uM Nigericinrespiration

0.127

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.613

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.609

menadione6-10 ug/mL Menadionerespiration

0.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.112

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.941

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.408

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.147

NRP_1Non-replicating persistence stage 1dosRassociated

-0.112

Amp0.2mg/mL AmpicillincellWall

-0.189

Cephalexin20-100 ug/mL CephalexincellWall

0.099

Cerulenin0.32-5 ug/mL CerulenincellWall

1.325

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.794

EMB10-20 ug/mL EthambutolcellWall

0.025

Eta12-40 ug/mL EthionamidecellWall

0.804

INH0.2-0.4 ug/mL IsoniazidcellWall

0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.409

BZA0.12 mg/mL BenzamidearomaticAmides

-0.176

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.018

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.404

H2O24 mM hydrogen peroxideDNAdamaging

-0.310

Levo10 ug/mL LevofloxacinDNAdamaging

-0.154

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.184

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.444

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.399

Antimycin12.5-50 ug/mL Antimycin A?

0.734

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.378

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.254

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.533

PA8240.2-2 ug/mL PA-824?

1.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.438

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.404

Verapamil50 uM Verapamil?

1.139

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.374

methoxatin10-20 ug/mL Methoxatin?